Αρχειοθήκη ιστολογίου

Σάββατο 14 Απριλίου 2018

Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016

grey_pxl.gif

Publication date: Available online 14 April 2018
Source:Annales de Dermatologie et de Vénéréologie
Author(s): C. Hurabielle, M. Battistella, C. Ram-Wolff, C. Fite, V. Meignin, J. Rivet, M.-D. Vignon-Pennamen, T. de Risi-Pugliese, E. Raffoux, B. Arnulf, E. Oksenhendler, F. Sicre de Fontbrune, R. Peffault de Latour, G. Socié, J.-D. Bouaziz, C. Lebbé, A. Bensussan, M. Bagot
IntroductionAdult T-cell leukemia/lymphoma (ATLL) is a hematological malignancy associated with chronic HTLV-1 infection.AimTo describe skin lesions in ATLL.MethodsA descriptive, retrospective study between 1996 and 2016, including all patients diagnosed with ATLL at Saint-Louis Hospital (Paris, France).ResultsThirty-seven ATLL patients were included. Fifteen patients (41%) had a cutaneous localization of the disease, which was present from the beginning of the disease for two thirds of them. ATLL types in patients with cutaneous localization of the disease were as follows: lymphoma, n=5, chronic, n=4, smoldering, n=4, acute, n=2. Half the patients had 2 or more cutaneous manifestations. The cutaneous localizations observed were as follows: nodulotumoral (n=8), plaques (n=7), multipapular (n=6), macular (n=4), purpuric (n=2). Among the 15 patients with cutaneous localization, median overall survival was significantly shorter in the acute and lymphoma types compared to the smoldering and chronic types (8.7 months vs. 79 months, P=0.003).DiscussionATLL is a hematologic malignancy with variable expression that is diagnosed only very rarely in metropolitan France, but that should be sought in patients from countries with high HTLV-1 prevalence in the event of a chronic eruption with patches, papules, plaques and/or tumors. The chronic and smoldering types are relatively indolent, whereas the acute and lymphoma forms have a poor prognosis.



https://ift.tt/2H1EVj9

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου